Literature DB >> 35393318

Defining timeliness in care for patients with lung cancer: a scoping review.

Adnan Ansar1,2, Virginia Lewis3,4, Christine Faye McDonald2,5,6, Chaojie Liu7, Muhammad Aziz Rahman2,4,8,9,10.   

Abstract

OBJECTIVES: Early diagnosis and reducing the time taken to achieve each step of lung cancer care is essential. This scoping review aimed to examine time points and intervals used to measure timeliness and to critically assess how they are defined by existing studies of the care seeking pathway for lung cancer.
METHODS: This scoping review was guided by the methodological framework for scoping reviews by Arksey and O'Malley. MEDLINE, EMBASE, CINAHL and PsycINFO electronic databases were searched for articles published between 1999 and 2019. After duplicate removal, all publications went through title and abstract screening followed by full text review and inclusion of articles in the review against the selection criteria. A narrative synthesis describes the time points, intervals and measurement guidelines used by the included articles.
RESULTS: A total of 2113 articles were identified from the initial search. Finally, 68 articles were included for data charting process. Eight time points and 14 intervals were identified as the most common events researched by the articles. Eighteen different lung cancer care guidelines were used to benchmark intervals in the included articles; all were developed in Western countries. The British Thoracic Society guideline was the most frequently used guideline (20%). Western guidelines were used by the studies in Asian countries despite differences in the health system structure.
CONCLUSION: This review identified substantial variations in definitions of some of the intervals used to describe timeliness of care for lung cancer. The differences in healthcare delivery systems of Asian and Western countries, and between high-income countries and low-income-middle-income countries may suggest different sets of time points and intervals need to be developed. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  PREVENTIVE MEDICINE; PRIMARY CARE; PUBLIC HEALTH; RESPIRATORY MEDICINE (see Thoracic Medicine); Respiratory tract tumours

Mesh:

Year:  2022        PMID: 35393318      PMCID: PMC8990712          DOI: 10.1136/bmjopen-2021-056895

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  88 in total

1.  Time to diagnosis and treatment for cancer patients in the Netherlands: Room for improvement?

Authors:  Charles C W Helsper; Nicole N F van Erp; Petra P H M Peeters; Niek N J de Wit
Journal:  Eur J Cancer       Date:  2017-11-13       Impact factor: 9.162

2.  Timeliness of Care and Lung Cancer Tumor-Stage Progression: How Long Can We Wait?

Authors:  Amelia W Maiga; Stephen A Deppen; Rhonda Pinkerman; Carol Callaway-Lane; Pierre P Massion; Robert S Dittus; Eric S Lambright; Jonathan C Nesbitt; David Baker; Eric L Grogan
Journal:  Ann Thorac Surg       Date:  2017-10-21       Impact factor: 4.330

Review 3.  How long is too long? A scoping review of health system delays in lung cancer.

Authors:  Ashanya Malalasekera; Sharon Nahm; Prunella L Blinman; Steven C Kao; Haryana M Dhillon; Janette L Vardy
Journal:  Eur Respir Rev       Date:  2018-08-29

4.  Delays in the diagnostic pathways for primary pulmonary carcinoma in Southern Norway.

Authors:  Heidi B Rolke; Per S Bakke; Frode Gallefoss
Journal:  Respir Med       Date:  2006-12-05       Impact factor: 3.415

5.  Delays in the diagnosis and treatment of primary lung cancer: are longer delays associated with advanced pathological stage?

Authors:  Adnan Yilmaz; Ebru Damadoglu; Cuneyt Salturk; Erdal Okur; Leyla Yagci Tuncer; Semih Halezeroglu
Journal:  Ups J Med Sci       Date:  2008       Impact factor: 2.384

6.  Factors contributing to the time taken to consult with symptoms of lung cancer: a cross-sectional study.

Authors:  S M Smith; N C Campbell; U MacLeod; A J Lee; A Raja; S Wyke; S B Ziebland; E M Duff; L D Ritchie; M C Nicolson
Journal:  Thorax       Date:  2008-12-03       Impact factor: 9.139

7.  Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study.

Authors:  Regina M Vidaver; Marianna B Shershneva; Scott J Hetzel; Timothy R Holden; Toby C Campbell
Journal:  J Oncol Pract       Date:  2016-05-03       Impact factor: 3.840

8.  Hospital characteristics associated with timeliness of care in veterans with lung cancer.

Authors:  Ellen M Schultz; Adam A Powell; Alex McMillan; Julie K Olsson; Mark A Enderle; Barry A Graham; Diana L Ordin; Michael K Gould
Journal:  Am J Respir Crit Care Med       Date:  2008-10-23       Impact factor: 21.405

9.  Audit of referral pathways in the diagnosis of lung cancer: a pilot study.

Authors:  Geraldine Largey; Samantha Chakraborty; Tracey Tobias; Peter Briggs; Danielle Mazza
Journal:  Aust J Prim Health       Date:  2015       Impact factor: 1.307

10.  Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.

Authors:  Melina Arnold; Mark J Rutherford; Aude Bardot; Jacques Ferlay; Therese M-L Andersson; Tor Åge Myklebust; Hanna Tervonen; Vicky Thursfield; David Ransom; Lorraine Shack; Ryan R Woods; Donna Turner; Suzanne Leonfellner; Susan Ryan; Nathalie Saint-Jacques; Prithwish De; Carol McClure; Agnihotram V Ramanakumar; Heather Stuart-Panko; Gerda Engholm; Paul M Walsh; Christopher Jackson; Sally Vernon; Eileen Morgan; Anna Gavin; David S Morrison; Dyfed W Huws; Geoff Porter; John Butler; Heather Bryant; David C Currow; Sara Hiom; D Max Parkin; Peter Sasieni; Paul C Lambert; Bjørn Møller; Isabelle Soerjomataram; Freddie Bray
Journal:  Lancet Oncol       Date:  2019-09-11       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.